论文部分内容阅读
慢性缺氧血性肺原性心脏病(简称肺原性心脏病)的基本治疗方法虽已有定论,但对每一项治疗方法的估价,以及在某些具体情况下的治疗方法选择问题,尚有值得进一步探讨之处。为此,本文从我院四年来收治的82例肺原性心脏病患者中,选取符合下列四项条件者40例,对后述的两个治疗问题进行探讨。选例标准为:(1)具有肺部原发性疾病,如各种病因所致的肺气肿或胸廓畸形等;(2)胸部 X 线检查显示肺动脉段突出,有或无右心室肥大;(3)心电图检查显示右心室肥大,有或无肺型 P 波者;(4)临床上具有明显的心力衰竭征象,同时能排除其它器质性心脏病者。抗菌素和洋地黄在心肺功能衰竭
Although the basic treatment of chronic anoxic pulmonary heart disease (referred to as pulmonary heart disease) has been conclusive, but the valuation of each treatment, as well as the choice of treatment options in some specific cases There is something worth exploring further. To this end, this article from our hospital in the past four years admitted 82 cases of patients with pulmonary heart disease, selected in line with the following four conditions in 40 cases, the treatment of the two discussed later. Selection criteria are: (1) with primary pulmonary disease, such as various causes of emphysema or thoracic deformity; (2) chest X-ray examination showed prominent pulmonary artery segment, with or without right ventricular hypertrophy; (3) ECG showed right ventricular hypertrophy, with or without pulmonary P wave; (4) clinically significant signs of heart failure, and can rule out other organic heart disease. Antibiotics and digitalis in cardiopulmonary failure